Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms, Plasma Cell × isatuximab × 90 days × Clear all

Sponsor

Conditions

Multiple Myeloma 19 Recurrence 2 Renal Insufficiency 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Paraproteinemias 1 Neoplasms 1 Neoplasm, Residual 1 Lymphoproliferative Disorders 1 Immunoproliferative Disorders 1 Hematologic Neoplasms 1

Interventions

Dexamethasone 8 Lenalidomide 7 Bortezomib 5 pomalidomide 3 carfilzomib 3 Calcium Dobesilate 3 Prednisone 2 poly ICLC 1 ibrutinib 1 fludarabine 1 elotuzumab 1 daratumumab 1 citarinostat 1 belantamab mafodotin 1 Whole-Body Irradiation 1 Transplantation 1 Tacrolimus 1 Sirolimus 1 PVX-410 vaccine 1 Mycophenolic Acid 1 Melphalan 1 Granulocyte Colony-Stimulating Factor 1 Everolimus 1 Cyclophosphamide 1 Clonal Hematopoiesis 1 Chromatin Immunoprecipitation Sequencing 1 Blood Cell Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡